Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet

Monday, December 31, 2018

Adamis Pharmaceuticals Corporation today announced the submission of a New Drug Application NDA to the US Food and Drug Administration FDA for its fastdissolving sublingual tadalafil tablet This product candidate is designed for the treatment of erec...

InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer

Saturday, December 29, 2018

InventisBio Shanghai announced today that it has signed a Collaboration Agreement with Betta Pharma hereinafter referred to as Betta Pharma Under this agreement InventisBio will outlicense Ds right in China including mainland China Hong Kong and Taiw...

Hebrew University to Collaborate With KYORIN

Friday, December 28, 2018

Yissum the Technology Transfer Company of The Hebrew University of Jerusalem and KYORIN Pharmaceutical Co Ltd Tokyo Japan a subsidiary of KYORIN Holdings Inc which is engaged in the development and commercialization of prescription drugs announced to...

Delcath Announces Commercial Licensing Agreement for CHEMOSAT®

Thursday, December 27, 2018

Delcath Systems Inc an interventional oncology company focused on the treatment of primary and metastatic liver cancers announces that the company has entered into a definitive licensing agreement for CHEMOSAT commercialization in Europe with medac G...

Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers

Wednesday, December 26, 2018

Pharma major Lupin Limited Lupin and global biopharmaceutical company AbbVie Inc today announced that AbbVie has licensed Lupins MALT MucosaAssociated Lymphoid Tissue Lymphoma Translocation Protein inhibitor program Through this partnership AbbVie g...

Recro Pharma Amends IV Meloxicam License Agreement with Alkermes

Monday, December 24, 2018

Recro Pharma Inc a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings today announced an amendment to its global licensing agreement with Alkermes Pharma Ireland Limited Alkermes...

Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company

Monday, December 24, 2018

Windtree Therapeutics Inc a biotechnology company focused on developing aerosolized KL surfactant therapies for respiratory diseases and CVie Investments Limited CVie together with its whollyowned subsidiary CVie Therapeutics Limited a privatelyheld...

Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies

Friday, December 21, 2018

Gilead Sciences Inc and Agenus Inc announced today the companies have entered into an immunooncology IO partnership focused on the development and commercialization of up to five novel immunooncology therapies Under the terms of the agreement Agen...

Marken And TrakCel Collaborate To Serve Cell and Gene Trials

Friday, December 21, 2018

Marken announced a new collaboration with TrakCel the leading provider of fully integrated software for the comprehensive management and tracking of the many stages of the cell and gene therapy supply chain Cell and gene therapies represent a new...

Ascentage Pharma Announces Strategic Collaboration with Genor Biopharma

Thursday, December 20, 2018

Ascentage Pharma a global clinicalstage biopharmaceutical company dedicated to developing apoptosistargeted therapies for cancers and other diseases today announced that it has entered into a strategic collaboration with Genor Biopharma Co Ltd Genor...